Bristol Myers Squibb (BMY) EBITDA (2009 - 2026)
Bristol Myers Squibb's EBITDA came in at $954 million for Q2 2026, compared with -$588 million a year earlier and up 131.6% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Bristol Myers Squibb reported EBITDA of $406 million; for FY2025, it came in at -$597 million.
- Going back by year, EBITDA was -$12.75 billion in FY2024, $7.51 billion in FY2023 (-4.4%), $7.85 billion in FY2022 (-11.2%) and $8.84 billion in FY2021.
- The Q2 2026 figure represents the highest quarterly EBITDA since Q3 2024.
- The fastest year-over-year change in EBITDA over five years came in Q1 2023 (growth of 46.3%), and the weakest in Q1 2026 (a decline of 56.6%).
- Business Quant data shows BMY's EBITDA at $412 million (Q1 2026), -$1.65 billion (Q4 2025) and $690 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Bristol Myers Squibb | 120.21 Bn | 71.48 Bn | 9.25 Bn | 954.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 954.00 Mn |
| Mar 31, 2026 | 412.00 Mn |
| Dec 31, 2025 | -1.65 Bn |
| Sep 30, 2025 | 690.00 Mn |
| Jun 30, 2025 | -588.00 Mn |
| Mar 31, 2025 | 950.00 Mn |
| Dec 31, 2024 | -2.76 Bn |
| Sep 30, 2024 | 1.31 Bn |
| Jun 30, 2024 | 615.00 Mn |
| Mar 31, 2024 | -11.92 Bn |
| Dec 31, 2023 | 1.39 Bn |
| Sep 30, 2023 | 2.07 Bn |
| Jun 30, 2023 | 1.42 Bn |
| Mar 31, 2023 | 2.63 Bn |
| Dec 31, 2022 | 1.79 Bn |
| Sep 30, 2022 | 2.44 Bn |
| Jun 30, 2022 | 1.82 Bn |
| Mar 31, 2022 | 1.80 Bn |
| Dec 31, 2021 | 2.08 Bn |
| Sep 30, 2021 | 2.59 Bn |
API Access
Bristol Myers Squibb EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();